DrugPatentWatch Database Preview
Auranofin - Generic Drug Details
What are the generic sources for auranofin and what is the scope of auranofin freedom to operate?
There are seven drug master file entries for auranofin. One supplier is listed for this compound.
Summary for auranofin
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 7 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 17 |
| Clinical Trials: | 12 |
| Patent Applications: | 3 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | auranofin at DailyMed |
Medical Subject Heading (MeSH) Categories for auranofin
Synonyms for auranofin
| (1-Thio-.beta.-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate |
| [1-(Thio-|ES)-|A-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)gold |
| 34031-32-8 |
| 4-(2-aminoethyl)benzene sulfonyl fluoride hydrochloride |
| AC1OCFGC |
| AKOS026750078 |
| B7687 |
| CA003139 |
| CA009493 |
| CTK8F7877 |
| D0L2UN |
| FT-0662343 |
| Gold, (1-thio-.beta.-D-glucopyranosato)(triethylphosphine)-, 2,3,4,6-tetraacetate |
| GOLD(1+) ION [3,4,5-TRIS(ACETYLOXY)-6-[(ACETYLOXY)METHYL]OXAN-2-YL]SULFANIDE TRIETHYLPHOSPHINE |
| gold(1+); (2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate; triethylphosphane |
| KS-00001FB9 |
| MMV688978 |
| Ridaura (TN) |
| Ridauran |
| SCHEMBL5188854 |
| SK&F 39162 |
| SK&F-39162 |
US Patents and Regulatory Information for auranofin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for auranofin
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Sebela Ireland Ltd | RIDAURA | auranofin | CAPSULE;ORAL | 018689-001 | May 24, 1985 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
